Generics Industry News Search
 |
|
|
|
|
|
|
August 2004 News Archive |
|
|
| |
|
WOODCLIFF LAKE, N.J., Aug. 10; Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that its subsidiary, Barr Laboratories, Inc., has entered into an agreement with Cephalon, Inc. that will provide the Company with a license to manufacture and market a generic version of Cephalon's ACTIQ(R) ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Basel, 16 August 2004 - Novartis AG announced today that its Sandoz generics business unit has completed the acquisition of Sabex Holdings Ltd., a leading Canadian generics pharmaceutical manufacturer in a USD 565 million cash transaction that officially closed on August 13. Sabex ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Jerusalem, Israel, August 17, 2004- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has reached an agreement to acquire Pfizer's Italian generic pharmaceutical marketing company, Dorom S.r.l. The cash transaction, which is valued at up to 2.3 times sales, subject to adjustments...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
MIAMI - August 18, 2004 - IVAX Corporation (AMEX: IVX, LSE: IVX.L) announced today that it has commenced the initial commercialization of its gabapentin tablets in 100 mg, 300 mg and 400 mg strengths to selected customers....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
MIAMI - August 19, 2004 - IVAX Corporation (AMEX: IVX, LSE: IVX.L) announced today that contrary to a report issued by World Markets Research Centre on a recent court decision regarding Alphapharm ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Tokyo (JCNN) - Nichi-iko Pharmaceutical announced on August 20 that it has agreed with Maruko Pharmaceutical, a Nagoya-based pharmaceutical firm, to enter into a partnership.Under the terms of the agreement...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
MIAMI - August 20, 2004 - IVAX Corporation (AMEX: IVX) said that the Federal District Court in New Jersey denied the motion of plaintiff Pfizer Inc. for a temporary restraining order and preliminary injunction which sought to block the sale by IVAX of gabapentin tablet...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
Mylan Also Announces Tentative Approval for Cetirizine Hydrochloride Tablets and Sertraline Hydrochloride Tablets
PITTSBURGH, Aug. 23: Mylan Laboratories Inc. (NYSE: MYL) today announced that the U.S. Food and Drug Administration (FDA) has granted final approval for Mylan Pharmaceuticals' Abbreviated New Drug Application (ANDA) for Metoprolol Tartrate and Hydrochlorothiazide...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
N.J., Aug 27, 2004 -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that Barr Laboratories, Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of GlaxoSmithKline's Zofran ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
GlaxoSmithKline (GSK) today announced further action to help tackle the HIV/AIDS pandemic in South Africa. GSK has granted a voluntary licence under its patents to Feza Pharmaceuticals, a South African joint venture between Creative Outsourcing Solutions International...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Aug 30, 2004 /PRNewswire-FirstCall via COMTEX/ -- Mylan Laboratories Inc. (NYSE: MYL) today announced that Mylan Pharmaceuticals Inc. has filed a notice of voluntary dismissal without prejudice in the United States District Court for the Northern District of West Virginia...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
